Healthcare Finance Staff
The Commonwealth of Pennsylvania, Department of Public Welfare, has awarded CGI a contract renewal worth $44.9 million to help prevent, detect, deter and correct improper payments within Pennsylvania's Medicaid Medical Assistance program.
A patient recruiter for a Houston-based durable medical equipment company is the latest to be convicted in court for a scheme in which Medicare was billed for wheelchairs supposedly damaged in a hurricane.
A leader of a prescription fraud scheme has been sentenced to six years in prison for healthcare fraud, HIPAA violations and aggravated identity theft.
Oregon lawmakers agreed to an 11.5 percent cut in Medicaid payments to hospitals instead of the 19 percent cut requested by Gov. John Kitzhaber for the 2011-2013 budget.
The American Medical Association is calling on the Federal Trade Commission and Department of Justice to make changes to their proposed policy regarding antitrust enforcement of accountable care organizations so that physicians in all practice sizes can develop, lead and actively participate in ACOs.
The sixth annual PayerView rankings place Aetna at top for performance across several survey segments. The PayerView Rankings are published each year by EHR company athenahealth and Physicians Practices, a practice management journal for physicians.
Beacon IPA, a one-year-old Long Island-based physician network consisting of almost 200 healthcare practitioners, has announced a three-year contract with Empire BlueCross BlueShield aimed at finding new ways to enhance the overall quality, efficiency and safety of clinical care and reduce costs.
A new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark has found that 45 percent of people who provide care to a family member are more likely to neglect their own prescription medications than they are to neglect medication for the person for whom they are caring.
South-central Maryland's Civista Health System will join the University of Maryland Medical System on July 1.
Baltimore-based Johns Hopkins Medicine and national drugstore chain Walgreens have entered into a wide-ranging agreement designed to promote collaboration on population-based research and develop protocols to improve outcomes of patients with chronic diseases.